Comparison of the Application of Allogeneic Fibroblast and Autologous Mesh Grafting With the Conventional Method in the Treatment of Third-Degree Burns.
Moravvej H, Hormozi AK, Hosseini SN, Sorouri R, Mozafari N, Ghazisaidi MR, Rad MM, Moghimi MH, Sadeghi SM, Mirzadeh H.
J Burn Care Res. 2016 Jan-Feb;37(1):e90-5. doi: 10.1097/BCR.0b013e31825aeac1.
[Study on the optimal ratio of autoskin and alloskin during mixed microskin grafting].
Lin H, Peng DZ, Yan Q, Dong ZX, Yue HL, Li F, Zhou X, Liu J.
Zhonghua Shao Shang Za Zhi. 2006 Feb;22(1):11-4.
Prolongation of alloskin graft survival by catalytic scavengers of reactive oxygen species.
Tocco G, Illigens BM, Malfroy B, Benichou G.
Cell Immunol. 2006 Jun;241(2):59-65. doi: 10.1016/j.cellimm.2006.06.009. Epub 2006 Sep 12.
Immunogenicity of glycerol-preserved human cadaver skin in vitro.
Richters CD, Hoekstra MJ, van Baare J, du Pont JS, Kamperdijk EW.
J Burn Care Rehabil. 1997 May-Jun;18(3):228-33. doi: 10.1097/00004630-199705000-00009.
Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway.
Wu T, Sun C, Chen Z, Zhen Y, Peng J, Qi Z, Yang X, Zhao Y.
J Immunol. 2012 Nov 15;189(10):4989-5000. doi: 10.4049/jimmunol.1200068. Epub 2012 Oct 8.
[The ectopic expression and quantitative analysis of Integrin beta1 during wound healing process after mixed microskin transplantation].
Lin H, Peng DZ, Yan Q, Zhou X, Liu J.
Zhonghua Shao Shang Za Zhi. 2008 Dec;24(6):445-9.
Chronic transplantation immunity in newts: temperature susceptibility of an effector phase in allo-skin graft rejection.
Kinefuchi K, Kushida Y, Johnouchi M, Shimizu Y, Ohneda H, Fujii M, Hosono M.
Zoolog Sci. 2011 Jul;28(7):509-16. doi: 10.2108/zsj.28.509.
Limitations of CD95 ligand-transduced killer dendritic cells to prevent graft rejections.
Kusuhara M, Matsue H.
Exp Dermatol. 2005 Apr;14(4):273-80. doi: 10.1111/j.0906-6705.2005.00307.x.
